In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 44 for your search:
Drug:  octreotide acetate
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CSMS995AUS38, STOP Trial, NCT00050635

2.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: Other
Protocol IDs: NeuroendoUnit-4, NCT00495846

3.

Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MSKCC-94133A1, NCI-V95-0664

4.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000065713, E-E1295, CLB-9770, SWOG-E1295, NCI-P97-0081, NCT00003057

5.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069304, NCCTG-N00CA, NCI-P02-0221, N00CA, NCT00033605

6.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-874652, MAYO-874652, NCCTG-87-46-52

7.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: any age
Sponsor: NCI
Protocol IDs: NCI-89-C-80, NCI-T89-0090N, T89-0090

8.

Phase: Phase III
Type: Treatment
Status: Closed
Age: postmenopausal
Sponsor: NCI
Protocol IDs: NCCTG-893253, MAYO-893253, MCGILL-ET-9110, NCCTG-89-32-53

9.

Phase: Phase III
Type: Treatment
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: NCCTG-894352, MAYO-894352, NCCTG-89-43-52

10.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG-0315, CDR0000349441, NCT00075868

11.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000440922, NCCTG-N04C2, N04C2, NCT00182754

12.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 85
Sponsor: Other
Protocol IDs: HCC-327-2000, NCT00121914

13.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CRAD001C2325, 2006-004507-18, NCT00412061

14.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Not specified
Sponsor: NCI
Protocol IDs: NCI-2009-00778, CDR0000579151, SWOG-S0518, S0518, U10CA032102, NCT00569127

15.

Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 18 to 70
Sponsor: Pharmaceutical / Industry
Protocol IDs: CSMS995AIC04, NCT00582426

16.

Phase: Phase III
Type: Treatment
Status: Completed
Age: postmenopausal
Sponsor: Other
Protocol IDs: MA14, CAN-NCIC-MA14, NCI-V96-1060, CDR0000065135, NCT00002864

17.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CSOM230C2402, 2009-016722-13, EUDRACT 2009-016722-13, NCT01137682

18.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000064787, NCCTG-947851, NCT00002779

19.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MAYO-917202, NCI-V96-1073

20.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor:
Protocol IDs: MSKCC-87094, NCI-V88-0389

21.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and older
Sponsor: NCI
Protocol IDs: NCCTG-898251, MAYO-898251, NCCTG-89-82-51

22.

Phase: Phase II
Type: Treatment
Status: Closed
Age: over 15 to less than 71
Sponsor:
Protocol IDs: MDA-ID-89003, NCI-V89-0131

23.

Phase: Phase II
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: MSKCC-90161, NCI-V91-0041

24.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: MGH-88-7553, NCI-V92-0042

25.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-922051, NCCTG-92-20-51
1   
New Search